Dermatology · West Palm Beach, FL
NPI
1336506260
Since 2016
Specialty
Dermatology
Code 207N00000X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
185 Banyan Blvd Fl 2
West Palm Beach, FL, 33401
Phone (305) 243-6704
Groups this clinician bills Medicare through
Medicare paid, 2024
$271K
3,231 services
Medicare patients, 2024
812
Average age 74
Drug cost, 2024
$946K
1,154 prescriptions
Company payments, 2025
$578K
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andrew S Dorizas was code 17003 (destruction skin lesion), 860 times for 144 patients. In total Andrew S Dorizas billed 3,231 services in 74 codes, and Medicare paid $271K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 860 | 144 | $5.24 | $4,509 |
| 11102 Skin Biopsy | Office | 385 | 352 | $71.89 | $28K |
| 99213 Office E&M - Established | Office | 369 | 293 | $73.12 | $27K |
| 99203 Office E&M - New | Office | 258 | 258 | $91.21 | $24K |
| 11103 Skin Biopsy | Office | 226 | 144 | $43.62 | $9,858 |
| 17000 Destruction Skin Lesion | Office | 200 | 175 | $38.25 | $7,650 |
| 99214 Office E&M - Established | Office | 172 | 149 | $104.19 | $18K |
| 17110 Destruction Skin Lesion | Office | 123 | 112 | $90.99 | $11K |
| 99204 Office E&M - New | Office | 110 | 110 | $137.34 | $15K |
| 17311 Mohs Surgery | Office | 97 | 91 | $598.60 | $58K |
| 17312 Mohs Surgery | Office | 43 | 38 | $377.85 | $16K |
| 99212 Office E&M - Established | Office | 43 | 36 | $42.59 | $1,831 |
| 11900 Skin | Office | 32 | 18 | $40.45 | $1,295 |
| 69100 Other Organ Systems | Office | 29 | 28 | $47.52 | $1,378 |
| 12032 Wound Repair - All Levels | Office | 27 | 25 | $199.91 | $5,398 |
By year: 2022 $71K for 1,327 services; 2023 $98K for 1,717 services; 2024 $271K for 3,231 services.
Medicare prescription drug claims, 2024
In 2024, the drug Andrew S Dorizas prescribed most often to Medicare patients was Ketoconazole, with 203 prescriptions and refills. In total Andrew S Dorizas wrote 1,154 Medicare prescriptions that cost $946K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 203 | 238 | 126 | $3,095 |
| Clobetasol Propionate Generic | 101 | 109 | 79 | $4,116 |
| Hydrocortisone Generic | 82 | 86 | 59 | $498 |
| Triamcinolone Acetonide Generic | 82 | 98 | 65 | $919 |
| Mupirocin Generic | 76 | 78 | 62 | $496 |
| Dupixent Pen Dupilumab | 63 | 63 | 11 | $248K |
| Doxycycline Hyclate Generic | 46 | 46 | 36 | $533 |
| Minoxidil Generic | 33 | 64 | 15 | $252 |
| Clindamycin Phosphate Generic | 31 | 37 | 14 | $766 |
| Ciclopirox Generic | 26 | 26 | Under 11 | $814 |
| Dutasteride Generic | 25 | 33 | Under 11 | $471 |
| Ammonium Lactate Generic | 20 | 29 | 16 | $458 |
| Pentoxifylline Generic | 19 | 24 | Under 11 | $162 |
| Gabapentin Generic | 19 | 29 | Under 11 | $116 |
| Tacrolimus Generic | 16 | 19 | Under 11 | $1,873 |
Brand drugs: 153 claims; generic drugs: 1,001 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrew S Dorizas $578K ($578K in general payments such as food, travel and fees) from 27 companies. The largest payer was UCB, Inc. with $113K.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 125 | $113K |
| Janssen Biotech, Inc. JNJ | 85 | $100K |
| Lilly USA, LLC LLY | 85 | $79K |
| Arcutis Biotherapeutics, Inc. ARQT | 60 | $58K |
| Incyte Corporation INCY | 73 | $56K |
| Galderma Laboratories, L.P. GALD.SW | 47 | $44K |
| LEO Pharma Inc. | 44 | $30K |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 18 | $30K |
| Amgen Inc. AMGN | 28 | $28K |
| Pfizer Inc. PFE | 27 | $27K |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.